- Maxim raises BeiGene Ltd BGNE price target from $160 to $200; Says the company continues to advance its clinical pipeline with multiple catalysts ahead and a strong balance sheet with runway well into 2020.
- B. Riley out defending Spectrum Pharmaceuticals, Inc. SPPI, expects shares to rebound as poziotinib represents 'a potential exciting new treatment for NSCLC patients'; Believes Spectrum is moving towards a U.S. breakthrough therapy filing.
- Morgan Stanley raises Seagate Technology PLC STC price target from $51 to $72 implying 28 percent upside. Says market is “underappreciating the money behind the growth in data storage.”
- Goldman Sachs downgrades Cognex Corporation CGNX, says 2018 is a “transition year” for the company and opex growth will put pressure on margins.
- Morgan Stanley upgrades NVIDIA Corporation NVDA from Equal-Weight to Overweight; Says data era now “Investable”and machine learning inference will be a “very important” market.
- Raymond James raises Netflix, Inc. NFLX price target from $290 to $330. While presence of the World Cup may affect Q2 guidance, firm says the company’s “core thesis” remains intact due to global market share gains, pricing power and margin expansion.
- Deutsche Bank maintains Buy rating on Philip Morris International PM; “Potentially heightened cash returns will form part of management's agenda in our view."
See Also:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in